Heterochromatin as an incubator for pathology and treatment non-response:Implication for neuropsychiatric illness

Pharmacogenomics Journal

Volumn 12, Issue 5, 2012, Pages 361-367

  Sharma, R P ^a   Gavin, D P ^a   Chase, K A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

chromosome; G9a; GLP; histone; histone methyltransferase; transcription

Indexed keywords

COCAINE; DNA; DNA METHYLTRANSFERASE; DNA METHYLTRANSFERASE 3A; DNA METHYLTRANSFERASE 3B; HETEROCHROMATIN PROTEIN 1; HISTONE DEACETYLASE INHIBITOR; HISTONE H3; HISTONE METHYLTRANSFERASE; HOMODIMER; N (1 BENZYL 4 PIPERIDINYL) 2 (HEXAHYDRO 4 METHYL 1H 1,4 DIAZEPIN 1 YL) 6,7 DIMETHOXY 4 QUINAZOLINAMINE; TRICHOSTATIN A;

CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOME SEGREGATION; CHRONIC DISEASE; CPG ISLAND; DNA METHYLATION; DOPAMINERGIC NERVE CELL; DRUG ABUSE; GENE EXPRESSION REGULATION; GENE REARRANGEMENT; GENE REGULATORY NETWORK; GENE REPRESSION; GENETIC ASSOCIATION; HETEROCHROMATIN; HISTONE METHYLATION; HUMAN; MEMORY; MENTAL DISEASE; NONHUMAN; PHARMACOGENOMICS; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; SCHIZOPHRENIA; TRANSACTIVATION; TRANSCRIPTION REGULATION;

ACETYLATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE EXPRESSION REGULATION; HETEROCHROMATIN; HISTOCOMPATIBILITY ANTIGENS; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; SCHIZOPHRENIA;

EID: 84866707137     PISSN: 1470269X     EISSN: 14731150     Source Type: Journal    
DOI: 10.1038/tpj.2011.64     Document Type: Review

References (47)

1. Epsztejn-Litman S, Feldman N, Abu-Remaileh M, Shufaro Y, Gerson A, Ueda J et al. De novo DNA methylation promoted by G9a prevents reprogramming of embryonically silenced genes. Nat Struct Mol Biol 2008; 15: 1176-1183.
2. Dong KB, Maksakova IA, Mohn F, Leung D, Appanah R, Lee S et al. DNA methylation in ES cells requires the lysine methyltransferase G9a but not its catalytic activity. EMBO J 2008; 27: 2691-2701.
3. Nguyen TT, Cho K, Stratton SA, Barton MC. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 2005; 25: 2147-2157.
4. El Gazzar M, Yoza BK, Chen X, Hu J, Hawkins GA, McCall CE. G9a and HP1 couple histone and DNA methylation to TNFalpha transcription silencing during endotoxin tolerance. J Biol Chem 2008; 283: 32198-32208.
5. Tachibana M, Sugimoto K, Nozaki M, Ueda J, Ohta T, Ohki M et al. G9a histone methyltransferase plays a dominant role in euchromatic histone H3 lysine 9 methylation and is essential for early embryogenesis. Genes Dev 2002; 16: 1779-1791.
6. Jiang Y, Jakovcevski M, Bharadwaj R, Connor C, Schroeder FA, Lin CL et al. Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B. J Neurosci 2010; 30: 7152-7167.
7. Wen B, Wu H, Shinkai Y, Irizarry RA, Feinberg AP. Large histone H3 lysine 9 dimethylated chromatin blocks distinguish differentiated from embryonic stem cells. Nat Genet 2009; 41: 246-250.
8. Shinkai Y, Tachibana M. H3K9 methyltransferase G9a and the related molecule GLP. Genes Dev 2011; 25: 781-788.
9. Byvoet P, Shepherd GR, Hardin JM, Noland BJ. The distribution and turnover of labeled methyl groups in histone fractions of cultured mammalian cells. Arch Biochem Biophys 1972; 148: 558-567.
10. Zee BM, Levin RS, Dimaggio PA, Garcia BA. Global turnover of histone post-translational modifications and variants in human cells. Epigenetics Chromatin 2010; 3: 22.
11. Jackson V, Shires A, Chalkley R, Granner DK. Studies on highly metabolically active acetylation and phosphorylation of histones. J Biol Chem 1975; 250: 4856-4863.
12. Hazzalin CA, Mahadevan LC. Dynamic acetylation of all lysine 4-methylated histone H3 in the mouse nucleus: Analysis at c-fos and cjun. PLoS Biol 2005; 3: e393.
13. Sharma RP. Schizophrenia, epigenetics and ligand-activated nuclear receptors: A framework for chromatin therapeutics. Schizophr Res 2005; 72: 79-90.
14. Dai B, Rasmussen TP. Global epiproteomic signatures distinguish embryonic stem cells from differentiated cells. Stem Cells 2007; 25: 2567-2574.
15. Collins R, Cheng X. A case study in cross-talk: The histone lysine methyltransferases G9a and GLP. Nucleic Acids Res 2010; 38: 3503-3511.
16. Davie JR. Nuclear matrix, dynamic histone acetylation and transcriptionally active chromatin. Mol Biol Rep 1997; 24: 197-207.
17. Katan-Khaykovich Y, Struhl K. Dynamics of global histone acetylation and deacetylation in vivo: Rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev 2002; 16: 743-752.
18. Goldmit M, Ji Y, Skok J, Roldan E, Jung S, Cedar H et al. Epigenetic ontogeny of the igk locus during B cell development. Nat Immunol 2005; 6: 198-203.
19. Hediger F, Gasser SM. Heterochromatin protein 1: Don't judge the book by its cover!. Curr Opin Genet Dev 2006; 16: 143-150.
20. Jacobs SA, Khorasanizadeh S. Structure of HP1 chromodomain bound to a lysine 9-methylated histone H3 tail. Science 2002; 295: 2080-2083.
21. Brasher SV, Smith BO, Fogh RH, Nietlispach D, Thiru A, Nielsen PR et al. The structure of mouse HP1 suggests a unique mode of single peptide recognition by the shadow chromo domain dimer. EMBO J 2000; 19: 1587-1597.
22. Guelen L, Pagie L, Brasset E, Meuleman W, Faza MB, Talhout W et al. Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions. Nature 2008; 453: 948-951.
23. Ayyanathan K, Lechner MS, Bell P, Maul GG, Schultz DC, Yamada Y et al. Regulated recruitment of HP1 to a euchromatic gene induces mitotically heritable, epigenetic gene silencing: A mammalian cell culture model of gene variegation. Genes Dev 2003; 17: 1855-1869.
24. Festenstein R, Pagakis SN, Hiragami K, Lyon D, Verreault A, Sekkali B et al. Modulation of heterochromatin protein 1 dynamics in primary mammalian cells. Science 2003; 299: 719-721.
25. Okada Y, Suzuki T, Sunden Y, Orba Y, Kose S, Imamoto N et al. Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: Role in nuclear egress of viral particles. EMBO Rep 2005; 6: 452-457.
26. Kind J, van Steensel B. Genome-nuclear lamina interactions and gene regulation. Curr Opin Cell Biol 2010; 22: 320-325.
27. Harmon B, Sedat J. Cell-by-cell dissection of gene expression and chromosomal interactions reveals consequences of nuclear reorganization. PLoS Biol 2005; 3: e67.
28. Grewal SI, Jia S. Heterochromatin revisited. Nat Rev Genet 2007; 8: 35-46.
29. Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman W et al. Molecular maps of the reorganization of genomenuclear lamina interactions during differentiation. Mol Cell 2010; 38: 603-613.
30. Baxter J, Sauer S, Peters A, John R, Williams R, Caparros ML et al. Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes. EMBO J 2004; 23: 4462-4472.
31. Gavin DP, Rosen C, Chase K, Grayson DR, Tun N, Sharma RP. Dimethylated lysine 9 of histone 3 is elevated in schizophrenia and exhibits a divergent response to histone deacetylase inhibitors in lymphocyte cultures. J Psychiatry Neurosci 2009; 34: 232-237.
32. Sharma RP, Rosen C, Kartan S, Guidotti A, Costa E, Grayson DR et al. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: Preliminary results from a clinical population. Schizophr Res 2006; 88: 227-231.
33. Maze I, Feng J, Wilkinson MB, Sun H, Shen L, Nestler EJ. Cocaine dynamically regulates heterochromatin and repetitive element unsilencing in nucleus accumbens. Proc Natl Acad Sci USA 2011; 108: 3035-3040.
34. Schaefer A, Sampath SC, Intrator A, Min A, Gertler TS, Surmeier DJ et al. Control of cognition and adaptive behavior by the GLP/G9a epigenetic suppressor complex. Neuron 2009; 64: 678-691.
35. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008; 2: 525-528.
36. Maze I, Covington HE, Dietz DM, LaPlant Q, Renthal W, Russo SJ et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010; 327: 213-216.
37. Rodriguez JJ, Garcia DR, Nakabeppu Y, Pickel VM. FosB in rat striatum: Normal regional distribution and enhanced expression after 6-month haloperidol administration. Synapse 2001; 39: 122-132.
38. Gupta S, Kim SY, Artis S, Molfese DL, Schumacher A, Sweatt JD et al. Histone methylation regulates memory formation. J Neurosci 2010; 30: 3589-3599.
39. Tsankova NM, Berton O, Renthal W, Kumar A, Neve RL, Nestler EJ. Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action. Nat Neurosci 2006; 9: 519-525.
40. Chang Y, Zhang X, Horton JR, Upadhyay AK, Spannhoff A, Liu J et al. Structural basis for G9a-like protein lysine methyltransferase inhibition by BIX-01294. Nat Struct Mol Biol 2009; 16: 312-317.
41. Feldman N, Gerson A, Fang J, Li E, Zhang Y, Shinkai Y et al. G9amediated irreversible epigenetic inactivation of oct-3/4 during early embryogenesis. Nat Cell Biol 2006; 8: 188-194.
42. Liu F, Chen X, Allali-Hassani A, Quinn AM, Wigle TJ, Wasney GA et al. Protein lysine methyltransferase G9a inhibitors: Design, synthesis, and structure activity relationships of 2,4-diamino-7-aminoalkoxy-quinazolines. J Med Chem 2010; 53: 5844-5857.
43. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, Cheng CS et al. Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 2007; 128: 505-518.
44. Hublitz P, Albert M, Peters AH. Mechanisms of transcriptional repression by histone lysine methylation. Int J Dev Biol 2009; 53: 335-354.
45. Bannister AJ, Zegerman P, Partridge JF, Miska EA, Thomas JO, Allshire RC et al. Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain. Nature 2001; 410: 120-124.
46. Bernstein BE, Meissner A, Lander ES. The mammalian epigenome. Cell 2007; 128: 669-681.
47. Sims III RJ, Nishioka K, Reinberg D. Histone lysine methylation: A signature for chromatin function. Trends Genet 2003; 19: 629-639.